Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects
Condition: Anxiety Disorders Interventions: Drug: Paroxetine IR tablets A; Drug: Paroxetine IR tablets B Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2017 Category: Research Source Type: clinical trials
